NeuroGenesis and Hadassah Medical Center Report Significant Results in Patients with Progressive Multiple Sclerosis Treated with NG-01 Autologous Cells Therapy
NeuroGenesis and Hadassah Medical Center announced highly positive results from a placebo-controlled Phase 2 clinical trial assessing the impact of […]